COVID-19 vaccine formula targets the XFG variant, in line withPublic Health recommendations to more closely match contemporary circulating variants; The vaccine will be ...

COVID-19 vaccine formula targets the XFG variant, in line with FDA guidance to more closely match contemporary circulating ...

BioNTech's colorectal cancer vaccine just collapsed in a Phase 2 trial, dragging Moderna down with it despite last week's melanoma triumph, and the fallout is forcing investors to rethink how far mRNA ...

BioNTech (BNTX) ADRs lost ~5% in the premarket on Thursday after Bloomberg News reported that Pfizer (PFE) is planning to sell its remaining stake in its partner, which helped the U.S. pharma giant to ...

The 2025-2026 COVID-19 vaccine formulation targets the SARS-CoV-2 sublineage LP.8.1, in line with FDA guidance to more closely match circulating strains1 Shipping of the LP.8.1-adapted vaccine will ...

Wondering how Pfizer and partner BioNTech developed a COVID-19 vaccine in record time without compromising safety? Dr Bill ...

The Food and Drug Administration approved new seasonal Covid-19 vaccine formulas made by Moderna, Pfizer and BioNTech.

Add Yahoo as a preferred source to see more of our stories on Google. Pfizer Inc. signage is seen on July 22, 2020 in New York City. Pfizer and partner BioNTech said they will halt a ...

NEW YORK & MAINZ, Germany--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced a new agreement with the European Commission (EC) to supply 900 million doses of ...

This real-world study, conducted between September and December 2024, also showed that the impact of symptoms on daily activities, including work and family responsibilities, was lower in recipients ...

Canadian operation Pfizer Canada ULC and BioNTech (BNTX) said Thursday that Health Canada has authorized XFG-adapted COMIRNATY COVID-19 vaccine for individuals aged 6 months and older. The updated ...